Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News $
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2013's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on LGND
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
LIGAND PHARMA (NQ:LGND)
Delayed:
32.33
-0.21 (0.65%)
Trade Now!
Previous Close
$32.54
52 Week High
$33.86
Open
$32.59
52 Week Low
$12.56
Day High
$32.63
P/E
N/A
Day Low
$31.42
EPS
$-0.01
Volume
170,042
Friends, Peers and Foes
(?)
:
ONXX
,
GSK
,
PFE
,
ISRG
PZE
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
Jun 13, 2013 07:59 AM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Sabba Stephen L
Jun 13, 2013 07:55 AM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: KNOTT DAVID M
Jun 12, 2013 05:13 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Patel Sunil
Jun 12, 2013 05:13 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: LAMATTINA JOHN L
Jun 12, 2013 05:12 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: KOZARICH JOHN W
Jun 12, 2013 05:12 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Davis Todd C
Jun 12, 2013 05:12 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Aryeh Jason
Jun 12, 2013 05:03 PM
Form 8-K LIGAND PHARMACEUTICALS For: Jun 11
Jun 4, 2013 08:04 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 03 Filed by: HIGGINS JOHN L
Jun 4, 2013 08:03 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 03 Filed by: FOEHR MATTHEW W
View All Articles
May 8, 2013 04:14 PM
Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 7c; Approves $5M Buyback
Feb 13, 2013 04:18 PM
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 EPS of $0.19
Dec 4, 2012 08:42 AM
Ligand Pharma (LGND) Issues FY13 Outlook into Analyst Day
Nov 5, 2012 05:11 PM
Ligand Pharmaceuticals, Inc. (LGND) Misses Q3 EPS by 5c
Nov 5, 2012 04:02 PM
Ligand Pharma (LGND) to Restate FY11, Q112, Q212 Financials
Oct 22, 2012 08:33 AM
Ligand Pharmaceuticals (LGND) Announces $2M Milestone Payment, Affirms 2012 Revenue Guidance
Aug 8, 2012 04:38 PM
Ligand Pharmaceuticals, Inc. (LGND) Misses Q2 EPS by 18c
May 2, 2012 04:33 PM
Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 9c
Feb 7, 2012 04:49 PM
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 Earnings of $0.24, Offers FY12 Sales Guidance
Nov 8, 2011 04:13 PM
Ligand Pharmaceuticals, Inc. (LGND) Misses Q3 EPS by 21c
View All Major News
May 20, 2013 06:45 AM
Ligand Pharmaceuticals (LGND) Agreement with Merck KGaA Unit Terminated
May 8, 2013 04:14 PM
Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 7c; Approves $5M Buyback
Feb 13, 2013 04:18 PM
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 EPS of $0.19
Jan 4, 2013 08:02 AM
Cantor Fitzgerald Downgrades Ligand Pharma (LGND) to Hold
Dec 13, 2012 05:12 PM
FDA Accepts Pfizer (PFE) Ligand (LGND) NDA For Bazedoxifene/Conjugated Estrogens
Dec 4, 2012 08:42 AM
Ligand Pharma (LGND) Issues FY13 Outlook into Analyst Day
Nov 19, 2012 01:02 PM
Unusual 11 Mid-Day Movers 11/19: (BMTI) (CAK) (UTSI) Higher; (TSTC) (LRN) (DMND) Lower
Nov 19, 2012 09:45 AM
Ligand Pharma (LGND) shares resume trading; shares up ~8%
Nov 19, 2012 09:20 AM
Ligand Pharma (LGND) to resume trading at 9:45AM after FDA approval
Nov 19, 2012 09:11 AM
Ligand (LGND), Glaxo (GSK) Receive FDA Approval for PROMACTA in HCV Patients
View All Reports
May 29, 2013 08:30 AM
Ligand Provides New Corporate Presentation at Investor Conference
May 23, 2013 08:30 AM
Ligand to Present at Upcoming Investor Conferences
May 14, 2013 08:30 AM
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV
May 8, 2013 04:00 PM
Ligand Reports First Quarter Financial Results
Apr 30, 2013 05:50 AM
Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA
Apr 26, 2013 08:30 AM
Ligand Presents Preclinical Data on HepDirect™ Liver-Targeting Technology Platform at 2013 International Liver Congress (EASL) Annual Meeting
Apr 23, 2013 09:00 AM
Ligand to Present at Upcoming Investor Conferences
Apr 22, 2013 09:00 AM
Ligand to Report First Quarter Results on May 8th
View All Press Releases
Jun 13, 2013 07:59 AM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Sabba Stephen L
Jun 13, 2013 07:55 AM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: KNOTT DAVID M
Jun 12, 2013 05:13 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Patel Sunil
Jun 12, 2013 05:13 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: LAMATTINA JOHN L
Jun 12, 2013 05:12 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: KOZARICH JOHN W
Jun 12, 2013 05:12 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Davis Todd C
Jun 12, 2013 05:12 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 11 Filed by: Aryeh Jason
Jun 12, 2013 05:03 PM
Form 8-K LIGAND PHARMACEUTICALS For: Jun 11
Jun 4, 2013 08:04 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 03 Filed by: HIGGINS JOHN L
Jun 4, 2013 08:03 PM
Form 4 LIGAND PHARMACEUTICALS For: Jun 03 Filed by: FOEHR MATTHEW W
View All Filings
Entities mentioned with
LGND
Earnings
|
View Related Stories »
Third Point LLC
|
View Related Stories »
Daniel Loeb
|
View Related Stories »
Citi
|
View Related Stories »
Twitter
|
View Related Stories »
Bank of America
|
View Related Stories »
Greenlight Capital
|
View Related Stories »
Trading Radar
|
View Related Stories »
JPMorgan
|
View Related Stories »
David Einhorn
|
View Related Stories »
Hedge Funds
|
View Related Stories »
Cantor Fitzgerald
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Barclays
|
View Related Stories »
Bankruptcy
|
View Related Stories »
Stock Buyback
|
View Related Stories »
Dividend
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Nelson Peltz
|
View Related Stories »
Merriman Curhan Ford
|
View Related Stories »
GLG Partners
|
View Related Stories »
Morning Movers
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Show More...
View All Entities